FemTech (FemTech) has recently attracted global attention. It seeks to apply the latest technologies such as IT to the treatment of infertility such as egg freezing, fetal monitoring, women’s cancer detection and other aspects related to women’s health and well-being. For this purpose, the development of emerging technologies and the exploration of business opportunities All are constantly in progress. Although the FemTech market is still in its infancy stage, its scale is growing rapidly, and CBInsights estimates that it will reach US$50 billion in 2025.
According to the Nikkei and Nikkan Kogyo Shimbun reports, it is estimated that the current global FemTech market size is about 35 billion U.S. dollars, and it is expected to grow by 43% to 50 billion U.S. dollars by 2025, and the potential scale may be even larger. FemTech used to focus on the care of women during pregnancy and menstruation. In the early days, menstrual management apps were the main focus. For example, the LunaLuna App launched by Nissho MTI has ushered in its 20th anniversary. By manually inputting menstrual periods, users can predict their menstrual cycle and even It is a psychological change caused by hormones, and it can also help to observe health conditions.
Click on the picture to enlarge it
FemTech’s concerns have recently extended to gynecological diseases that cause infertility and menstrual problems. In addition, because some elderly diseases are common in women, for example, women with Alzheimer’s disease account for two-thirds of all patients. As the population structure ages in the future, it is expected that the demand for health care for middle-aged and elderly women will also increase.
Investment in women’s health-related companies has become increasingly active in recent years. In 2020, the total amount of financing reached nearly 1.7 billion U.S. dollars, a record high. The accelerators and incubation centers that were born in response to the needs of new startups are also very active.
COVID-19 (new crown pneumonia) is raging around the world. According to statistics, the risk of infection and post-infection mortality of pregnant women in the United States are increasing. From this case, it can be seen that telemedicine is more necessary to avoid direct contact between pregnant women or other patients and medical staff. It is now possible to use mobile device apps or remote remote control devices to collect health information, and strive to detect diseases at an early stage or observe the condition, or monitor the vital signs of the fetus in real time.
It is estimated that the rate of prenatal and postnatal depression symptoms found by the App is nearly three times that of the US Centers for Disease Control and Prevention (CDC). In addition, the industry has successively invested in the development of educational apps for women’s health issues, and expanded functions to allow patients to use online consultation services. Companies are racing to develop a variety of digital platforms, through online medical and lifestyle guidance, to establish personalized consulting services for women.
Compared with men, women’s chronic disease related clinical data is scarce. In addition to the American company Pollie setting up a female hormone balance management platform to provide online medical services to meet patients’ needs for medical resources and information, Israeli company MobileODT also uses artificial intelligence (AI) Screen for cervical cancer.